

SciSparc (NASDAQ: SPRC) stock soared over 18% on high volume after announcing a strategic expansion into agentic AI and cybersecurity.
You can purchase shares of SciSparc (NASDAQ:SPRC) through any online brokerage.
Other companies in SciSparc’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
There is no analysis for SciSparc to provide a consensus price target.
The stock price for SciSparc (NASDAQ: SPRC) is $0.82 last updated October 28, 2026 at 4:38 PM EDT.
There are no upcoming dividends for SciSparc.
SciSparc does not have any upcoming earnings scheduled.
There is no upcoming split for SciSparc.
SciSparc is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and...